Courtesy of Benzinga.
Sequenom, Inc. (NASDAQ: SQNM) yesterday announced that it has filed a motion for preliminary injunction against Aria Diagnostics to stop Aria from making, using, selling or offering for sale, importing or exporting, infringing tests for detecting fetal chromosomal aneuploidy, such as Aria’s Harmony Prenatal Test™, pending the ultimate resolution of the litigation.
Sequenom’s request for preliminary injunction follows the lawsuit filed on January 24, 2012, in the United States District Court for the Southern District of California, which alleges that Aria infringes U.S. Patent No. 6,258,540. Sequenom is requesting that the district court quickly intervene to stop Aria Diagnostics’ continued infringement of the ’540 patent.